Graf Akcie BASI (Bioanalytical Systems Inc.). Diskuze k akciím BASI. Aktuální informace BASI.

Základní informace o společnosti Bioanalytical Systems Inc. (Akcie BASI)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 172.46M
Hodnota podniku (EV) N/A
Tržby N/A
EBITDA N/A
Zisk -3.63
Růst v tržbách Q/Q 38.45 %
Růst v tržbách Y/Y 36.58 %
P/E (Cena vůči ziskům) 0.00
Forward P/E -78.29
EV/Sales 3.76
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 2.64
P/FCF N/A
Price/Book 22.78
Účetní hodnota na akcii 0.72
Hotovost na akcii N/A
FCF vůči ceně -2.33 %
Počet zaměstnanců 17,000
Tržba na zaměstnance N/A
Profit margin -7.75 %
Operating margin -2.80 %
Gross margin 30.16 %
EBIT margin -2.80 %
EBITDA margin 4.31 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst N/A %
EPS - Očekávaný růst příští rok N/A %
Return on assets -5.81 %
Return on equity -42.53 %
ROIC -3.72 %
ROCE -6.48 %
Dluhy/Equity 7.13
Čistý dluh/EBITDA 44.63
Current ratio 0.46
Quick Ratio 0.44
Volatilita 9.95
Beta 0.21
RSI 51.12
Cílová cena analytiků 2
Známka akcie (dle analytiků) N/A
Insider ownership 34.92 %
Institutional ownership 10.67 %
Počet akcií 11.131M
Procento shortovaných akcií 0.67 %
Short ratio 0.53 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1997
Země United States

Finanční výsledky akcie BASI

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$60.469$43.616$26.346$24.242$20.441$22.698
Cost Of Goods Sold$42.232$29.581$18.23$16.545$16.016$15.209
Gross Profit$18.237$14.035$8.116$7.697$4.425$7.489
Research And Development Expenses$0.95$0.627$0.596$0.465$0.496$0.715
SG&A Expenses$20.35$13.561$7.506$5.954$5.998$6.47
Other Operating Income Or Expenses-----$0.605
Operating Expenses$63.532$43.769$26.332$22.964$23.481$21.789
Operating Income$-3.063$-0.153$0.014$1.278$-3.04$0.909
Total Non-Operating Income/Expense$-1.475$-0.633$-0.268$-0.37$-0.204$0.205
Pre-Tax Income$-4.538$-0.786$-0.254$0.908$-3.244$1.114
Income Taxes$0.147$0.004$-0.06$0.024$-0.014$0.015
Income After Taxes$-4.685$-0.79$-0.194$0.884$-3.23$1.099
Other Income------
Income From Continuous Operations$-4.685$-0.79$-0.194$0.884$-3.23$1.099
Income From Discontinued Operations------
Net Income$-4.685$-0.79$-0.194$0.884$-3.23$1.099
EBITDA$1.011$2.564$1.889$2.958$-0.513$2.346
EBIT$-3.063$-0.153$0.014$1.278$-3.04$0.909
Basic Shares Outstanding11109888
Shares Outstanding11109989
Basic EPS$-0.43$-0.08$-0.02$0.11$-0.40$0.14
EPS - Earnings Per Share$-0.43$-0.08$-0.02$0.10$-0.40$0.07
# 2020 2019 2018 2017 2016 2015
Current Ratio0.48350.70980.68310.6870.3620.7176
Long-term Debt / Capital0.7130.56250.44090.3330.02590.2582
Debt/Equity Ratio4.23931.54980.88010.54080.71570.4508
Gross Margin30.159332.178630.805431.750721.647732.9941
Operating Margin-5.0654-0.35080.05315.2718-14.87214.0048
EBIT Margin-5.0654-0.35080.05315.2718-14.87214.0048
EBITDA Margin1.67195.87867.1712.202-2.509710.3357
Pre-Tax Profit Margin-7.5047-1.8021-0.96413.7456-15.87014.9079
Net Profit Margin-7.7478-1.8113-0.73643.6466-15.80164.8418
Asset Turnover0.98181.0390.84261.18730.96740.9531
Inventory Turnover Ratio60.331427.014615.42318.121611.022710.3745
Receiveable Turnover5.58714.58156.38237.70819.12545.6759
Days Sales In Receivables65.329379.66857.189747.352739.99864.3068
ROE - Return On Equity-61.8809-7.4005-1.788211.8945-51.490511.5163
Return On Tangible Equity453.5321-18.7649-4.316910.4876-43.53111.3078
ROA - Return On Assets-7.6064-1.8818-0.62044.3297-15.28714.6147
ROI - Return On Investment-17.702-3.227-0.99666.9639-42.18917.5992
Book Value Per Share0.69191.01891.06241.02710.91981.3236
Operating Cash Flow Per Share-0.0522-0.22650.25610.0107-0.10850.0277
Free Cash Flow Per Share0.0388-0.73890.14490.1269-0.1004-0.0738